PVLA
Palvella Therapeutics
PVLA
PVLA
71 hedge funds and large institutions have $115M invested in Palvella Therapeutics in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 20 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
12% less funds holding
Funds holding: 81 → 71 (-10)
15% less capital invested
Capital invested by funds: $136M → $115M (-$20.9M)
53% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 19
Holders
71
Holding in Top 10
2
Calls
$591K
Puts
$68K
Top Buyers
| 1 | +$10.4M | |
| 2 | +$2.28M | |
| 3 | +$1.97M | |
| 4 |
ACM
Aquilo Capital Management
San Francisco,
California
|
+$1.55M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$1.26M |
Top Sellers
| 1 | -$2.71M | |
| 2 | -$2.66M | |
| 3 | -$2.03M | |
| 4 |
Millennium Management
New York
|
-$1.56M |
| 5 |
Goldman Sachs
New York
|
-$871K |